Parexel International Clinical Research Private Limited, a active private limited company, was established on 24 April 2006 in Bengaluru, Karnataka, India. Engaging in pharma contract r&d within the information and communication sector, it holds CIN: U74220KA2006PTC039077. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.40 M.
Formerly known as Parexel International Synchron Private Limited. It upholds a compliant status. Employing 74 professional, Its leadership includes Sanjay Champalal Vyas (Director), Michael Francis Crowley Iii (Director), John Ronald James Benoit (Director). Past directors included Sanjay Champalal Vyas, Paul Joseph Armstrong, Shujath Bin Ali. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Cowrks Rmz Ecoworld, Ground Floor Bay Area Adj To Building 6A, Orr,Devarabeesanahalli Vill, Age, Bengaluru, Karnataka, 560103.
U74220KA2006PTC039077
039077
24 April 2006
₹1.00 Cr
₹0.40 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Parexel International Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Champalal Vyas | Director | 27 Jun 2019 | Current |
| Michael Francis Crowley Iii | Director | 20 Dec 2017 | Current |
| John Ronald James Benoit | Director | 01 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 11 Dec 2020 | Past |
| Pramod Abcsdd | Director | 27 Jun 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2018 | Past |
| Pramod Abcsdd | Director | 01 May 2020 | Past |
| Pramod Abcsdd | Director | 23 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Parexel International Clinical Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.24% increase. The company also saw a substantial fall in profitability, with a 36.02% decrease in profit. The company's net worth moved up by a moderate rise of 9.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Parexel International Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Parexel International Clinical Research has a workforce of 74 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Parexel International Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parexel International Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Parexel International Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Parexel International Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
Progress on John Ronald James Benoit was appointed as a Director was appointed as a Director on 01 Jul 2024 & has been associated with this company since 1 year 6 months . was documented.
Sanjay Champalal Vyas was appointed as a Director was appointed as a Director on 27 Jun 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
Michael Francis Crowley Iii was appointed as a Director was appointed as a Director on 20 Dec 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
Progress on Parexel International Clinical Research Private Limited was registered on 24 Apr 2006 with Roc Bangalore & aged 19 years 8 months as per MCA records. was documented.
/PRNewswire/ -- At the Intelligent Medicines' Future Decoded event co-hosted by Microsoft, Indegene and PAREXEL, life sciences leaders reunited at the....
The CIN of Parexel International Clinical Research Private Limited is U74220KA2006PTC039077.
Parexel International Clinical Research Private Limited is headquartered at Cowrks Rmz Ecoworld, Ground Floor Bay Area Adj To Building 6A, Orr,Devarabeesanahalli Vill, Age, Bengaluru, Karnataka, 560103.
Parexel International Clinical Research Private Limited was incorporated on 24 April 2006.
The current directors of Parexel International Clinical Research Private Limited are
The primary industry of Parexel International Clinical Research Private Limited is Information And Communication.
Parexel International Clinical Research Private Limited is unlisted.
The authorized capital of Parexel International Clinical Research Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.40 M.
The compliance status of Parexel International Clinical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX